-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Titan Medical (TSE:TMD) Trading Up 7.1%
Titan Medical (TSE:TMD) Trading Up 7.1%
Titan Medical Inc. (TSE:TMD – Get Rating)'s share price was up 7.1% during mid-day trading on Tuesday . The company traded as high as C$1.24 and last traded at C$1.20. Approximately 28,127 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 58,968 shares. The stock had previously closed at C$1.12.
Titan Medical Stock Performance
The business's fifty day moving average is C$1.01 and its 200-day moving average is C$0.77. The stock has a market capitalization of C$130.91 million and a PE ratio of -10.64. The company has a quick ratio of 1.18, a current ratio of 1.41 and a debt-to-equity ratio of 21.28.
Get Titan Medical alerts:Titan Medical (TSE:TMD – Get Rating) last released its earnings results on Thursday, November 10th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, analysts anticipate that Titan Medical Inc. will post -1.9800001 EPS for the current fiscal year.
Titan Medical Company Profile
(Get Rating)Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.
See Also
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Titan Medical Inc. (TSE:TMD – Get Rating)'s share price was up 7.1% during mid-day trading on Tuesday . The company traded as high as C$1.24 and last traded at C$1.20. Approximately 28,127 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 58,968 shares. The stock had previously closed at C$1.12.
泰坦醫療股份有限公司(TSE:TMD-獲取評級)的股價在周二中間交易期間上漲了 7.1%。該公司的交易價格高達 1.24 加元,最後交易價格為 1.20 加元。日間交易期間成交約 28,127 股股份,較每日平均成交量 58,968 股下跌 52%。該股票之前已收盤 1.12 加元。
Titan Medical Stock Performance
泰坦醫療股票表現
The business's fifty day moving average is C$1.01 and its 200-day moving average is C$0.77. The stock has a market capitalization of C$130.91 million and a PE ratio of -10.64. The company has a quick ratio of 1.18, a current ratio of 1.41 and a debt-to-equity ratio of 21.28.
該業務的五十天移動平均線為 1.01 加元,其 200 天移動平均線為 0.77 加元。該股的市值為 130.91 萬加元,私募股票的私募比率為 -10.64。該公司的快速比率為 1.18,流動比率為 1.41,債務與權益比率為 21.28。
Titan Medical (TSE:TMD – Get Rating) last released its earnings results on Thursday, November 10th. The company reported C($0.12) earnings per share (EPS) for the quarter. As a group, analysts anticipate that Titan Medical Inc. will post -1.9800001 EPS for the current fiscal year.
泰坦醫療(TSE:TMD-獲取評級)上次公佈了 11 月 10 日(星期四)的盈利結果。該公司報告了該季度每股盈利(0.12 美元)。作為一個集團,分析師預計泰坦醫療股份有限公司將在本會計年度公佈 -1.9800001 每股盈餘。
Titan Medical Company Profile
泰坦醫療公司簡介
Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.
Titan Medical Inc. 是一家醫療技術公司,專注於機器人輔助手術技術的開發和商業化,以應用於微創手術。它正在開發 Eos 系統,一種機器人單一進入手術系統,該系統包括一個外科手術控制的患者推車,該手術包括 3D 高清視覺系統和用於執行外科手術的多關節儀器;以及在外科手術期間為外科醫生提供符合人體工程學的接口,以及患者身體內的 3D 內窺鏡視圖。
See Also
另請參閱
- Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
- Mullen Automotive Stock Gains Momentum On Positive News
- Harley-Davidson Inc. Stock, Is It Time To Buy?
- The Bottom Is In For Meta Platforms, Volatility Is Not Over
- Analyzing Alaska Air's Recent Earnings
- 凱西·伍茲的方舟創新 ETF 將在 2023 年反彈?
- 馬倫汽車股票在積極新聞中獲得動力
- 哈雷戴維森公司股票,是時候購買了嗎?
- 對於元平台來說,波動性還沒有結束
- 分析阿拉斯加航空的近期盈利
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收泰坦醫療日報的最新消息和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Titan Medical 和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧